Zanamivir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Uncomplicated acute illness due to influenza A and B infection (patients > 7 yrs of age with < 48hr symptoms).
  • Influenza prophylaxis in those 5 years of age or older.
    • Not proven effective for prophylaxis in nursing home residents.

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Uncomplicated acute illness due to influenza A and B infection (patients > 7 yrs of age with < 48hr symptoms).
  • Influenza prophylaxis in those 5 years of age or older.
    • Not proven effective for prophylaxis in nursing home residents.

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: December 6, 2017